SPERTI, COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 17.011
EU - Europa 2.659
AS - Asia 1.674
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 9
OC - Oceania 8
AF - Africa 1
Totale 21.376
Nazione #
US - Stati Uniti d'America 16.988
IT - Italia 879
CN - Cina 860
FI - Finlandia 534
SG - Singapore 529
SE - Svezia 345
UA - Ucraina 307
DE - Germania 295
VN - Vietnam 220
GB - Regno Unito 161
IE - Irlanda 50
FR - Francia 21
IN - India 21
CA - Canada 20
NL - Olanda 17
EU - Europa 13
GR - Grecia 13
IR - Iran 11
HK - Hong Kong 10
CH - Svizzera 9
KR - Corea 8
JP - Giappone 5
PL - Polonia 5
AU - Australia 4
CZ - Repubblica Ceca 4
NZ - Nuova Zelanda 4
AL - Albania 3
BR - Brasile 3
PH - Filippine 3
RU - Federazione Russa 3
TR - Turchia 3
AR - Argentina 2
BY - Bielorussia 2
CO - Colombia 2
ES - Italia 2
HU - Ungheria 2
MK - Macedonia 2
MX - Messico 2
PE - Perù 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
Totale 21.376
Città #
Fairfield 2.160
Woodbridge 1.836
Houston 1.628
Ann Arbor 1.468
Chandler 1.411
Ashburn 1.171
Jacksonville 1.093
Wilmington 921
Cambridge 723
Seattle 700
Princeton 612
Medford 388
Singapore 313
San Diego 282
Des Moines 265
Roxbury 233
Beijing 231
Dong Ket 220
Helsinki 215
Padova 187
Boardman 168
Nanjing 160
Guangzhou 62
Shenyang 59
Rome 58
Redwood City 55
Ogden 49
Milan 48
Nanchang 48
Dublin 45
Norwalk 43
Jiaxing 40
Changsha 38
Hebei 37
New York 35
London 32
Los Angeles 30
Kharkiv 26
Tianjin 26
Phoenix 20
Jinan 17
Naples 17
Turin 17
Brescia 14
Washington 14
Borås 13
Rockville 13
Palermo 12
Pune 12
Bologna 11
Pietro 10
Hefei 9
Legnaro 9
Venezia 9
Hong Kong 8
Kilburn 8
Lappeenranta 8
Shanghai 8
Taizhou 8
Bari 7
Chengdu 7
Chicago 7
Ningbo 7
Tappahannock 7
Ferrara 6
Genoa 6
Hounslow 6
Indiana 6
Kunming 6
Nürnberg 6
Orange 6
Redmond 6
Vigonza 6
Zhengzhou 6
Munich 5
San Francisco 5
Tehran 5
Auburn Hills 4
Groningen 4
Haikou 4
Lanzhou 4
Lucca 4
Montreal 4
New Bedfont 4
Pirri 4
Pomigliano d'Arco 4
Prescot 4
Radoslaw 4
Sommacampagna 4
Vicenza 4
Alonte 3
Cagliari 3
Camerata Picena 3
Cutrofiano 3
Detroit 3
Falls Church 3
Ghedi 3
Macerata 3
Malo 3
North York 3
Totale 17.545
Nome #
Liponecrosi sottocutanea metastatica da tumore acinoso del pancreas. 271
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 173
Duodenocefalopancreasectomia (DCP) 162
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 154
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial 150
Serous cystic neoplasm of the pancreas: A multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 148
Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade. 146
Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature 143
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 142
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival 141
Duodenum-preserving versus pylorus-preserving pancreatic head resection for benign and premalignant lesions. 133
Diabetes and the risk of pancreatic cancer. 128
Aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: case report and review of the literature. 126
Adrenal metastasis from endometrial cancer: A case report 124
18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas. 121
Abdominal localization of Tangier disease mimicking a pancreatic neoplasm. 121
CA 19-9 as a prognostic index after resection for pancreatic cancer. 120
Livelli ematici di testosterone e gonadotropine ipofisarie nel cancro del pancreas e nella pancreatite cronica. 119
Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature. 118
Actinomycosis mimicking pancreatic neuroendocrine tumor. Case report and review of the literature 114
Pancreatic resection in very elderly patients: A critical analysis of existing evidence 109
Surgery for Recurrent Pancreatic Cancer: Is It Effective? 106
Distal pancreatectomy for body-tail pancreatic cancer: is there a role for celiac axis resection? 102
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 102
Solid-pseudopapillary tumor of the pancreas: A single center experience 102
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 102
Pancreatic resection for metastatic tumors to the pancreas 99
Prevention of Clinically-relevant Postoperative Pancreatic Fistula After Pancreticoduodenectomy 98
Metastatic tumors to the pancreas: The role of surgery. 98
Hormonal treatment of advanced pancreatic cancer with LH-RH analogue 97
Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. 96
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms 96
Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer 95
Ranitidine reverses cimetidine induced mental confusion in a patient with Zollinger-Ellison Syndrome. 94
CA 50 as a serum marker for pancreatic carcinoma: comparison with CA 19-9. 93
Androgen metabolism and pancreatic cancer. 93
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 92
Pancreaticoduodenectomy with unusual artery reconstruction in a patient with celiac axis occlusion: report of a case 91
18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. 89
Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat. 89
Survival rates and cause of death in 174 patients with chronic pancreatitis. 88
Pancreatic melanoma metastasis diagnosed by endoscopic ultrasound-guided SharkCore biopsy 88
Résultats de la duodénopancréatectomie chez les octogénaires: expérience monocentrique et revue de la littérature 88
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 88
Parenchyma-sparing resection for pancreatic neoplasms 87
TheTERTgene harbors multiple variants associated with pancreatic cancer susceptibility 87
Central venous catheter guidewire replacement according to the Seldinger technique: usefulness in the management of patients on total parenteral nutrition. 86
Duodenal leiomyosarcoma and its multiple recurrences: good surgical result after three years of follow-up. 85
Utilità  delle sacche in Etil- Vinil- Acetato per la nutrizione parenterale in chirurgia. 84
Multimodality treatment of recurrent pancreatic cancer: Mith or reality? 84
Tumor Relapse after Pancreatic Cancer Resection is Detected Earlier by 18-FDG PET than by CT. 83
Cystic neoplasms of the pancreas. 83
Leiomyosarcoma of the Pancreas with Liver Metastases as a Paradigm of Multimodality Treatment: Case Report and Review of the Literature. 82
Metastatic tumors to the pancreas: what is the optimal treatment? 81
Efficacy of a pancreatic enzyme formulation in the treatment of steatorrhea in patients with chronic pancreatitis. 81
FDG-PET Incidental Detection of Second Cancer During Investigation for Pancreatic Diseases. 81
Multimodal management of recurrent pancreatic cancer. Myth or reality? 81
Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas. 81
Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy 79
45 years of experience in the surgical treatment of Pancreatic Insulinoma. 79
18-FDG PET in differentiating malignant from benign pancreatic cysts: a prospective study 78
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 78
Forecast of surgical risk in pancreatic cancer. 78
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 78
Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer 78
Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms. 77
Huge cystic lymphangioma of the pancreas mimicking pancreatic cystic neoplasm. 77
CA 50 compared with CA 19-9 as a serum tumor marker for pancreatic carcinoma. 76
General aspects of surgical treatment of pancreatic cancer 76
Ductal adenocarcinoma of the body and tail of the pancreas. 76
The need of a severity scoring system for postoperative pancreatic fistulas. 76
Effect of castration and testosterone replacement on pancreatic carcinogenesis in Syrian hamsters. 76
A tricky case of pancreatic arteriovenous malformation: the role of endoscopic ultrasound in the diagnosis of this rare condition 76
Role of surgery in the treatment of bilio-pancreatic cancer. The European experience 75
Tumor-Associated Antigen: Clinical practice and future. 75
Primary clear cell carcinoma of exocrine pancreas. 75
Histology of the spleen in Immune Thrombocytopenia: clinical-pathological characterization and prognostic implications 75
Neuroendocrine tumor imaging: can 18-FDG Positron Emission Tomography detect tumors with poor prognosis and aggressive behavior? 73
Results using the human fibrin sealant (Tisseel) in the treatment of severe fistulas. 73
The effect of age on long-term survival after pancreatic resection for pancreatic cancer. 73
Adenosquamous pancreatic cancer: report of four cases. 73
Distal Pancreatectomy for Neuroendocrine Pancreatic Tumors. 73
Adenosquamous pancreatic cancer: 10 years of experience in a center. 72
Mo1441 Lymph Node Ratio and Para-Aortic Node Involvement Are Not Independent Predictors of Survival After Resection for Pancreatic Cancer 72
Mixed Endocrine- ExocrineTumors of the Pancreas. 71
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 71
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 71
Adenosquamous carcinoma of the papilla of Vater associated with a small bowel GIST. A case report. 71
The Role of Positron Emission Tomography in Clinical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas 71
Maldi-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and Complement C3. 70
Epstein-Barr virus-associated acute acalcolous cholecystitis in an adult 70
18-FDG PET is very useful in detecting tumor relapse after potentially curative resection of a pancreatic or periampullary cancer 69
Acinar cell carcinoma of the pancreas associated with subcutaneous panniculitis. 69
Duodenal Leiomiosarcoma mimiking a pancreatic pseudocyst. 69
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 69
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 69
Metastatic tumors to the pancreas: a systematic review and meta-analysis 69
ZOLLINGER-ELLISON SYNDROME: SURGICAL TREATMENT FOR "CURE" OR LONG-TERM PALLIATION. 68
Metastasis to the Pancreas from Colorectal Cancer: Is There a Place for Pancreatic Resection? 68
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer. 68
Totale 9.395
Categoria #
all - tutte 78.073
article - articoli 57.036
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.814
Totale 137.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.823 0 110 60 344 320 283 251 375 288 393 225 174
2020/20212.872 100 195 125 286 117 230 53 282 388 369 331 396
2021/20224.278 75 888 281 384 158 228 154 420 133 79 320 1.158
2022/20233.400 872 235 85 369 582 396 18 209 408 24 149 53
2023/20242.155 86 249 163 194 160 228 113 157 102 72 279 352
2024/202576 73 3 0 0 0 0 0 0 0 0 0 0
Totale 21.784